Chris Porter is Professor of Pharmaceutics at the Monash Institute of Pharmaceutical Sciences and Associate Dean (Research) at the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University, Melbourne. He completed his undergraduate and graduate studies at the University of Nottingham in the UK before moving to Australia to establish his academic career at Monash University. His research program is focused on the problems surrounding the absorption of poorly water soluble, lipophilic drugs and in particular the use of lipid based delivery systems to enhance oral bioavailability and stimulate lymphatic transport. He also has broader interests in mechanisms of intracellular drug disposition and targeted drug delivery – in particular the use of dendrimers as site-specific delivery systems. Dr Porter has published more than 200 peer reviewed papers and book chapters in these areas and his work has been cited >10,000 times. He was named as a Thompson Reuters Highly Cited researcher in Pharmacology and Toxicology in 2015. He has trained more than 40 PhDs and post-doctoral fellows. He is a Fellow of AAPS and the Royal Australian Chemical Society and a previous member of the board of scientific advisors of CRS. He is a current member of the Editorial Boards of Molecular Pharmaceutics, Pharmaceutical Research, the Journal of Pharmaceutical Sciences and the Journal of Pharmacy and Pharmacology.